Global Allergy Diagnostics and Therapeutics Market Research and Analysis, 2015-2022
MARKET INSIGHTS
The Global Allergy Diagnostics and Therapeutics market is anticipated to grow with a CAGR 12.3% during the forecasted period 2017-2022. Increasing prevalence of the allergic diseases across the globe is one of the key factors that are augmenting the growth of the market. Additionally, increasing environmental pollution, rising health care expenditure, increasing demand of IVD test for treatment of allergic diseases and development of advanced diagnosis product are boosting the allergy diagnostics and therapeutics market across the globe.
Allergic rhinitis affects around 15-30% of the population across the globe. Allergic diseases are estimated to be the 6th leading cause of chronic diseases in the US. An estimated 50 million people in America suffer from the allergies every year. Increasing environmental pollution is also one of the major factors driving the growth of the market. According to WHO, approximately 90% of the cities in emerging economies and more than 55% of cities in developed countries fail to comply with WHO air quality guidelines. Increasing healthcare expenditure across the globe is also one of the major factors driving the growth of the global allergy diagnostics and therapeutics market.
However, there are certain factors that are affecting the growth of the market which includes stringent government regulations on the use of medical devices, lack of awareness, and high cost of treatment are the major factors that are hindering the growth of the market. Except these petty challenges global allergy diagnostics and therapeutic market is yet to explore its full potential across the globe. Increasing demand from the emerging economies such as India and China are developing numerous expansion opportunities for the growth of the market.
GEOGRAPHICAL INSIGHTS
The global allergy diagnosis and therapeutics market is analyzed on the basis of the geographically region that are contributing significantly towards the growth of the market. Market on the basis of the geography is bifurcated into North America, Europe, Asia Pacific and Rest of the World. North America is estimated to be the leading region in the global allergy diagnosis and therapeutics market owing to increasing prevalence of allergic diseases in the region. Allergies affect about 50 million people in the Unites States every year. Asia Pacific is estimated to be the fastest growing region during the forecast period due to rising allergy patients and favorable government policies. Increasing pharmaceuticals market in Asia and increasing demand from developing countries such as India and China are driving the growth of the market.
COMPETITIVE INSIGHTS
The global allergy diagnosis and therapeutics market revolves around the market of multinational players. However, some regional players also contributed significantly towards the growth of the market. Key players of the market are Biomérieux, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., Siemens AG, Thermo Fisher Scientific, Inc, Hob Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Inc, Omega Diagnostics Group PLC and so on. In order to sustain in the market, these players adopt different strategies such as merger acquisitions, product launch and so on. For example, In 2016, Thermofisher Scientific acquired Field Electrone & Ion(FEI)company in $4.2 billion deal.
MARKET SEGMENTATION
1. Allergy diagnostics and therapeutics market by allergens
2. Allergy diagnostics and therapeutics market by product
3. Allergy diagnostics and therapeutics market by test
4. Allergy diagnostics and therapeutics market by drug class
5. Allergy diagnostics and therapeutics market by end-user
OMR REPORT COVERS:
The Global Allergy Diagnostics and Therapeutics market is anticipated to grow with a CAGR 12.3% during the forecasted period 2017-2022. Increasing prevalence of the allergic diseases across the globe is one of the key factors that are augmenting the growth of the market. Additionally, increasing environmental pollution, rising health care expenditure, increasing demand of IVD test for treatment of allergic diseases and development of advanced diagnosis product are boosting the allergy diagnostics and therapeutics market across the globe.
Allergic rhinitis affects around 15-30% of the population across the globe. Allergic diseases are estimated to be the 6th leading cause of chronic diseases in the US. An estimated 50 million people in America suffer from the allergies every year. Increasing environmental pollution is also one of the major factors driving the growth of the market. According to WHO, approximately 90% of the cities in emerging economies and more than 55% of cities in developed countries fail to comply with WHO air quality guidelines. Increasing healthcare expenditure across the globe is also one of the major factors driving the growth of the global allergy diagnostics and therapeutics market.
However, there are certain factors that are affecting the growth of the market which includes stringent government regulations on the use of medical devices, lack of awareness, and high cost of treatment are the major factors that are hindering the growth of the market. Except these petty challenges global allergy diagnostics and therapeutic market is yet to explore its full potential across the globe. Increasing demand from the emerging economies such as India and China are developing numerous expansion opportunities for the growth of the market.
GEOGRAPHICAL INSIGHTS
The global allergy diagnosis and therapeutics market is analyzed on the basis of the geographically region that are contributing significantly towards the growth of the market. Market on the basis of the geography is bifurcated into North America, Europe, Asia Pacific and Rest of the World. North America is estimated to be the leading region in the global allergy diagnosis and therapeutics market owing to increasing prevalence of allergic diseases in the region. Allergies affect about 50 million people in the Unites States every year. Asia Pacific is estimated to be the fastest growing region during the forecast period due to rising allergy patients and favorable government policies. Increasing pharmaceuticals market in Asia and increasing demand from developing countries such as India and China are driving the growth of the market.
COMPETITIVE INSIGHTS
The global allergy diagnosis and therapeutics market revolves around the market of multinational players. However, some regional players also contributed significantly towards the growth of the market. Key players of the market are Biomérieux, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., Siemens AG, Thermo Fisher Scientific, Inc, Hob Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Inc, Omega Diagnostics Group PLC and so on. In order to sustain in the market, these players adopt different strategies such as merger acquisitions, product launch and so on. For example, In 2016, Thermofisher Scientific acquired Field Electrone & Ion(FEI)company in $4.2 billion deal.
MARKET SEGMENTATION
1. Allergy diagnostics and therapeutics market by allergens
2. Allergy diagnostics and therapeutics market by product
3. Allergy diagnostics and therapeutics market by test
4. Allergy diagnostics and therapeutics market by drug class
5. Allergy diagnostics and therapeutics market by end-user
OMR REPORT COVERS:
- Comprehensive research methodology of Global Allergy Diagnostics and Therapeutics Market
- This report also includes detailed and extensive market overview with Analyst insights & key market trends.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Allergy Diagnostics and Therapeutics Market
- Insights about market determinants which are stimulating the Global Allergy Diagnostics and Therapeutics Market
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. SURGING ENVIRONMENTAL POLLUTION
3.1.2. RISE IN GLOBAL HEALTHCARE EXPENDITURE
3.1.3. GROWING PREVALENCE OF ALLERGIC DISEASES
3.1.4. INCREASING DEMAND OF IVD TESTS FOR ALLERGY DIAGNOSIS
3.1.5. DEVELOPMENT OF TECHNOLOGICALLY ADVANCE DIAGNOSIS PRODUCT
3.2. RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATION
3.2.2. PRESENCE OF AMBIGUOUS REGULATORY FRAMEWORK
3.2.3. HIGH CAPITAL REQUIREMENTS
3.2.4. LACK OF AWARENESS
3.3. OPPORTUNITIES
3.3.1. INCREASING DEMAND FROM EMERGING MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ALLERGENS
4.1.1. DRUG ALLERGENS
4.1.2. INHALED ALLERGENS
4.1.3. FOOD ALLERGENS
4.1.4. OTHERS
4.2. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCT
4.2.1. ASSAY KITS
4.2.2. INSTRUMENTS
4.2.3.1. LUMINOMETERS
4.2.3.2. IMMUNOASSAY ANALYZER
4.2.3.3. ELISA ANALYZER
4.2.3.4. OTHERS
4.2.3. SERVICES
4.3. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TEST
4.3.1. IN-VIVO TEST
4.3.2. IN-VITRO TEST
4.4. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY DRUG CLASS
4.4.1. ANTIHISTAMINES
4.4.2. DECONGESTANTS
4.4.3. CORTICOSTEROIDS
4.4.4. MAST CELL STABILIZERS
4.4.5. LEUKOTRIENE INHIBITORS
4.4.6. NASAL ANTICHOLINERGIC
4.4.7. IMMUNOMODULATORS
4.4.8. AUTO INJECTABLE EPINEPHRINE
4.4.9. IMMUNOTHERAPY
4.5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY END-USER
4.5.1. HOSPITALS
4.5.2. DIAGNOSTIC LABORATORIES
4.5.3. ACADEMIC RESEARCH
4.5.4. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ALCON LABORETRIES, INC.
7.1.1. INTRODUCTION
7.1.2. ALCON PRODUCT PORTFOLIO
7.1.3. ALCON RECENT ACTIVITIES
7.2. ALLERCHECK, INC.
7.2.1. INTRODUCTION
7.2.2. ALLERCHECK, INC. PRODUCT PORTFOLIO
7.2.3. ALLERCHECK, INC. RECENT ACTIVITIES
7.3. ALLERGEN PLC
7.3.1. INTRODUCTION
7.3.2. ALLERGEN PLC PRODUCT PORTFOLIO
7.3.3. ALLERGEN PLC RECENT ACTIVITIES
7.4. ALLERGY THERAPEUTICS
7.4.1. INTRODUCTION
7.4.2. ALLERGY THERAPEUTICS RECENT ACTIVITIES
7.4.3. ALLERGYTHERAPEUTICS PRODUCT PORTFOLIO
7.5. BIOMÉRIEUX
7.5.1. INTRODUCTION
7.5.2. BIOMÉRIEUX RECENT ACTIVITIES
7.5.3. BIOMÉRIEUX PRODUCT PORTFOLIO
7.6. DANAHER CORPORATION
7.6.1. INTRODUCTION
7.6.2. DANAHER CORPORATION PRODUCT PORTFOLIO
7.6.3. DANAHER CORPORATION RECENT ACTIVITIES
7.7. HAL ALLERGY GROUP
7.7.1. INTRODUCTION
7.7.2. HAL ALLERGY RECENT ACTIVITIES
7.7.3. HAL ALLERGYPRODUCT PORTFOLIO
7.8. HITACHI CHEMICAL DIAGNOSTICS, INC.
7.8.1. INTRODUCTION
7.8.2. HITACHI CHEMICAL DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.8.3. HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
7.9. HOB BIOTECH GROUP
7.9.1. INTRODUCTION
7.9.2. HOB BIOTECH GROUP PRODUCT PORTFOLIO
7.9.3. HOB BIOTECH GROUP RECENT ACTIVITIES
7.10. HYCOR BIOMEDICAL
7.10.1. INTRODUCTION
7.10.2. HYCOR BIOMEDICAL PRODUCT PORTFOLIO
7.10.3. HYCOR BIOMEDICAL RECENT ACTIVITIES
7.11. LINCOLN DIAGNOSTICS, INC.
7.11.1. INTRODUCTION
7.11.2. LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.11.3. LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
7.12. MEDA PHARMACEUTICALS
7.12.1. INTRODUCTION
7.12.2. MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
7.12.3. MEDA PHARMACEUTICALS RECENT ACTIVITIES
7.13. NIDEC CORPORATION
7.13.1. INTRODUCTION
7.13.2. NIDEC CORPORATION PRODUCT PORTFOLIO
7.13.3. NIDEC CORPORATION RECENT ACTIVITIES
7.14. OMEGA DIAGNOSTICS GROUP PLC
7.14.1. INTRODUCTION
7.14.2. OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
7.14.3. OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
7.15. QUEST DIAGNOSTICS, INC.
7.15.1. INTRODUCTION
7.15.2. QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.15.3. QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
7.16. SCHERING-PLOUGH CORPORATION
7.16.1. INTRODUCTION
7.16.2. SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
7.16.3. SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
7.17. SIEMENS AG
7.17.1. INTRODUCTION
7.17.2. SIEMENS AG RECENT ACTIVITIES
7.17.3. SIEMENS AG RODUCT PORTFOLIO
7.18. STALLERGENES GREER
7.18.1. INTRODUCTION
7.18.2. STALLERGENES GREER PRODUCT PORTFOLIO
7.18.3. STALLERGENES GREER RECENT ACTIVITIES
7.19. THERMOFISHER
7.19.1. INTRODUCTION
7.19.2. THERMOFISHER RECENT ACTIVITIES
7.19.3. THERMOFISHER PRODUCT PORTFOLIO
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. SURGING ENVIRONMENTAL POLLUTION
3.1.2. RISE IN GLOBAL HEALTHCARE EXPENDITURE
3.1.3. GROWING PREVALENCE OF ALLERGIC DISEASES
3.1.4. INCREASING DEMAND OF IVD TESTS FOR ALLERGY DIAGNOSIS
3.1.5. DEVELOPMENT OF TECHNOLOGICALLY ADVANCE DIAGNOSIS PRODUCT
3.2. RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATION
3.2.2. PRESENCE OF AMBIGUOUS REGULATORY FRAMEWORK
3.2.3. HIGH CAPITAL REQUIREMENTS
3.2.4. LACK OF AWARENESS
3.3. OPPORTUNITIES
3.3.1. INCREASING DEMAND FROM EMERGING MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ALLERGENS
4.1.1. DRUG ALLERGENS
4.1.2. INHALED ALLERGENS
4.1.3. FOOD ALLERGENS
4.1.4. OTHERS
4.2. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCT
4.2.1. ASSAY KITS
4.2.2. INSTRUMENTS
4.2.3.1. LUMINOMETERS
4.2.3.2. IMMUNOASSAY ANALYZER
4.2.3.3. ELISA ANALYZER
4.2.3.4. OTHERS
4.2.3. SERVICES
4.3. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TEST
4.3.1. IN-VIVO TEST
4.3.2. IN-VITRO TEST
4.4. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY DRUG CLASS
4.4.1. ANTIHISTAMINES
4.4.2. DECONGESTANTS
4.4.3. CORTICOSTEROIDS
4.4.4. MAST CELL STABILIZERS
4.4.5. LEUKOTRIENE INHIBITORS
4.4.6. NASAL ANTICHOLINERGIC
4.4.7. IMMUNOMODULATORS
4.4.8. AUTO INJECTABLE EPINEPHRINE
4.4.9. IMMUNOTHERAPY
4.5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY END-USER
4.5.1. HOSPITALS
4.5.2. DIAGNOSTIC LABORATORIES
4.5.3. ACADEMIC RESEARCH
4.5.4. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ALCON LABORETRIES, INC.
7.1.1. INTRODUCTION
7.1.2. ALCON PRODUCT PORTFOLIO
7.1.3. ALCON RECENT ACTIVITIES
7.2. ALLERCHECK, INC.
7.2.1. INTRODUCTION
7.2.2. ALLERCHECK, INC. PRODUCT PORTFOLIO
7.2.3. ALLERCHECK, INC. RECENT ACTIVITIES
7.3. ALLERGEN PLC
7.3.1. INTRODUCTION
7.3.2. ALLERGEN PLC PRODUCT PORTFOLIO
7.3.3. ALLERGEN PLC RECENT ACTIVITIES
7.4. ALLERGY THERAPEUTICS
7.4.1. INTRODUCTION
7.4.2. ALLERGY THERAPEUTICS RECENT ACTIVITIES
7.4.3. ALLERGYTHERAPEUTICS PRODUCT PORTFOLIO
7.5. BIOMÉRIEUX
7.5.1. INTRODUCTION
7.5.2. BIOMÉRIEUX RECENT ACTIVITIES
7.5.3. BIOMÉRIEUX PRODUCT PORTFOLIO
7.6. DANAHER CORPORATION
7.6.1. INTRODUCTION
7.6.2. DANAHER CORPORATION PRODUCT PORTFOLIO
7.6.3. DANAHER CORPORATION RECENT ACTIVITIES
7.7. HAL ALLERGY GROUP
7.7.1. INTRODUCTION
7.7.2. HAL ALLERGY RECENT ACTIVITIES
7.7.3. HAL ALLERGYPRODUCT PORTFOLIO
7.8. HITACHI CHEMICAL DIAGNOSTICS, INC.
7.8.1. INTRODUCTION
7.8.2. HITACHI CHEMICAL DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.8.3. HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
7.9. HOB BIOTECH GROUP
7.9.1. INTRODUCTION
7.9.2. HOB BIOTECH GROUP PRODUCT PORTFOLIO
7.9.3. HOB BIOTECH GROUP RECENT ACTIVITIES
7.10. HYCOR BIOMEDICAL
7.10.1. INTRODUCTION
7.10.2. HYCOR BIOMEDICAL PRODUCT PORTFOLIO
7.10.3. HYCOR BIOMEDICAL RECENT ACTIVITIES
7.11. LINCOLN DIAGNOSTICS, INC.
7.11.1. INTRODUCTION
7.11.2. LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.11.3. LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
7.12. MEDA PHARMACEUTICALS
7.12.1. INTRODUCTION
7.12.2. MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
7.12.3. MEDA PHARMACEUTICALS RECENT ACTIVITIES
7.13. NIDEC CORPORATION
7.13.1. INTRODUCTION
7.13.2. NIDEC CORPORATION PRODUCT PORTFOLIO
7.13.3. NIDEC CORPORATION RECENT ACTIVITIES
7.14. OMEGA DIAGNOSTICS GROUP PLC
7.14.1. INTRODUCTION
7.14.2. OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
7.14.3. OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
7.15. QUEST DIAGNOSTICS, INC.
7.15.1. INTRODUCTION
7.15.2. QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.15.3. QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
7.16. SCHERING-PLOUGH CORPORATION
7.16.1. INTRODUCTION
7.16.2. SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
7.16.3. SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
7.17. SIEMENS AG
7.17.1. INTRODUCTION
7.17.2. SIEMENS AG RECENT ACTIVITIES
7.17.3. SIEMENS AG RODUCT PORTFOLIO
7.18. STALLERGENES GREER
7.18.1. INTRODUCTION
7.18.2. STALLERGENES GREER PRODUCT PORTFOLIO
7.18.3. STALLERGENES GREER RECENT ACTIVITIES
7.19. THERMOFISHER
7.19.1. INTRODUCTION
7.19.2. THERMOFISHER RECENT ACTIVITIES
7.19.3. THERMOFISHER PRODUCT PORTFOLIO
LIST OF TABLES
TABLE #1 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE #2 GLOBAL ASSAY KITS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #3 GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #4 GLOBAL IMMUNOASSAY ANALYZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #5 GLOBAL LUMINOMETERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #6 GLOBAL ELISA ANALYZER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #7 GLOBAL OTHER INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #8 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY ALLERGENS 2015-2022 ($ MILLION)
TABLE #9 GLOBAL DRUG ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #10 GLOBAL FOOD ALLERGENS MARKET RESEARCH AND ANALYSIS, BY CONNECTOR, 2015-2022 ($ MILLION)
TABLE #11 GLOBAL INHALED ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #12 GLOBAL OTHER ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #13 GLOBAL INTERNAL HEXAGONAL CONNECTORS MARKET RESEARCH AND ANALYSIS, BY TEST, 2015-2022 ($ MILLION)
TABLE #14 GLOBAL IN-VITRO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #15 GLOBAL IN-VIVO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #16 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DRUG CLASS, 2015-2022 ($ MILLION)
TABLE #17 GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #18 GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #19 GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, BY PRODUCT, 2015-2022 ($ MILLION)
TABLE #20 GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #21 GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #22 GLOBAL NASAL ANTICHOLINERGIC MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE #23 GLOBAL IMMUNOMODULATORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #24 GLOBAL AUTO INJECTABLE EPINEPHRINE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #25 GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #26 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END-USER 2015-2022 ($ MILLION)
TABLE #27 GLOBAL DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
TABLE #28 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #29 GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #30 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #31 BIOMÉRIEUX PRODUCT PORTFOLIO
TABLE #32 BIOMÉRIEUX RECENT ACTIVITIES
TABLE #33 DANAHER CORPORATION PRODUCT PORTFOLIO
TABLE #34 DANAHER CORPORATION RECENT ACTIVITIES
TABLE #35 HITACHI CHEMICAL DIAGNOSTICS, INC PRODUCT PORTFOLIO
TABLE #36 HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #37 SIEMENS AG PRODUCT PORTFOLIO
TABLE #38 SIEMENS AG RECENT ACTIVITIES
TABLE #39 THERMOFISHER PRODUCT PORTFOLIO
TABLE #40 THERMOFISHER RECENT ACTIVITIES
TABLE #41 HOB BIOTECH GROUP PRODUCT PORTFOLIO
TABLE #42 HOB BIOTECH GROUP RECENT ACTIVITIES
TABLE #43 HYCOR BIOMEDICAL PRODUCT PORTFOLIO
TABLE #44 HYCOR BIOMEDICAL RECENT ACTIVITIES
TABLE #45 LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE #46 LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #47 OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
TABLE #48 OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
TABLE #49 STALLERGENES GREER PRODUCT PORTFOLIO
TABLE #50 STALLERGENES GREER RECENT ACTIVITIES
TABLE #51 QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE #52 QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #53 HAL ALLERGY PRODUCT PORTFOLIO
TABLE #54 HAL ALLERGY RECENT ACTIVITIES
TABLE #55 ALCON PRODUCT PORTFOLIO
TABLE #56 ALCON RECENT ACTIVITIES
TABLE #57 ALLERCHECK, INC. PRODUCT PORTFOLIO
TABLE #58 ALLERCHECK, INC. RECENT ACTIVITIES
TABLE #59 NIDEC CORPORATION PRODUCT PORTFOLIO
TABLE #60 NIDEC CORPORATION RECENT ACTIVITIES
TABLE #61 ALLERGY THERAPEUTICS PRODUCT PORTFOLIO
TABLE #62 ALLERGY THERAPEUTICS RECENT ACTIVITIES
TABLE #63 MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE #64 MEDA PHARMACEUTICALS RECENT ACTIVITIES
TABLE #65 ALLERGEN PLC PRODUCT PORTFOLIO
TABLE #66 ALLERGEN PLC RECENT ACTIVITIES
TABLE #67 ALLERGON AB PRODUCT PORTFOLIO
TABLE #68 ALLERGON AB RECENT ACTIVITIES
TABLE #69 SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
TABLE #70 SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
TABLE #1 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE #2 GLOBAL ASSAY KITS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #3 GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #4 GLOBAL IMMUNOASSAY ANALYZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #5 GLOBAL LUMINOMETERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #6 GLOBAL ELISA ANALYZER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #7 GLOBAL OTHER INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #8 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY ALLERGENS 2015-2022 ($ MILLION)
TABLE #9 GLOBAL DRUG ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #10 GLOBAL FOOD ALLERGENS MARKET RESEARCH AND ANALYSIS, BY CONNECTOR, 2015-2022 ($ MILLION)
TABLE #11 GLOBAL INHALED ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #12 GLOBAL OTHER ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #13 GLOBAL INTERNAL HEXAGONAL CONNECTORS MARKET RESEARCH AND ANALYSIS, BY TEST, 2015-2022 ($ MILLION)
TABLE #14 GLOBAL IN-VITRO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #15 GLOBAL IN-VIVO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #16 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DRUG CLASS, 2015-2022 ($ MILLION)
TABLE #17 GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #18 GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #19 GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, BY PRODUCT, 2015-2022 ($ MILLION)
TABLE #20 GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #21 GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #22 GLOBAL NASAL ANTICHOLINERGIC MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE #23 GLOBAL IMMUNOMODULATORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #24 GLOBAL AUTO INJECTABLE EPINEPHRINE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #25 GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #26 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END-USER 2015-2022 ($ MILLION)
TABLE #27 GLOBAL DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
TABLE #28 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #29 GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #30 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #31 BIOMÉRIEUX PRODUCT PORTFOLIO
TABLE #32 BIOMÉRIEUX RECENT ACTIVITIES
TABLE #33 DANAHER CORPORATION PRODUCT PORTFOLIO
TABLE #34 DANAHER CORPORATION RECENT ACTIVITIES
TABLE #35 HITACHI CHEMICAL DIAGNOSTICS, INC PRODUCT PORTFOLIO
TABLE #36 HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #37 SIEMENS AG PRODUCT PORTFOLIO
TABLE #38 SIEMENS AG RECENT ACTIVITIES
TABLE #39 THERMOFISHER PRODUCT PORTFOLIO
TABLE #40 THERMOFISHER RECENT ACTIVITIES
TABLE #41 HOB BIOTECH GROUP PRODUCT PORTFOLIO
TABLE #42 HOB BIOTECH GROUP RECENT ACTIVITIES
TABLE #43 HYCOR BIOMEDICAL PRODUCT PORTFOLIO
TABLE #44 HYCOR BIOMEDICAL RECENT ACTIVITIES
TABLE #45 LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE #46 LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #47 OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
TABLE #48 OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
TABLE #49 STALLERGENES GREER PRODUCT PORTFOLIO
TABLE #50 STALLERGENES GREER RECENT ACTIVITIES
TABLE #51 QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE #52 QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE #53 HAL ALLERGY PRODUCT PORTFOLIO
TABLE #54 HAL ALLERGY RECENT ACTIVITIES
TABLE #55 ALCON PRODUCT PORTFOLIO
TABLE #56 ALCON RECENT ACTIVITIES
TABLE #57 ALLERCHECK, INC. PRODUCT PORTFOLIO
TABLE #58 ALLERCHECK, INC. RECENT ACTIVITIES
TABLE #59 NIDEC CORPORATION PRODUCT PORTFOLIO
TABLE #60 NIDEC CORPORATION RECENT ACTIVITIES
TABLE #61 ALLERGY THERAPEUTICS PRODUCT PORTFOLIO
TABLE #62 ALLERGY THERAPEUTICS RECENT ACTIVITIES
TABLE #63 MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE #64 MEDA PHARMACEUTICALS RECENT ACTIVITIES
TABLE #65 ALLERGEN PLC PRODUCT PORTFOLIO
TABLE #66 ALLERGEN PLC RECENT ACTIVITIES
TABLE #67 ALLERGON AB PRODUCT PORTFOLIO
TABLE #68 ALLERGON AB RECENT ACTIVITIES
TABLE #69 SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
TABLE #70 SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
LIST OF FIGURES
FIGURE #1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
COMPANIES MENTIONED
1. Alcon Laboretries
2. Allercheck INC.
3. Allergen PLC
4. Allergon AB
5. Allergy Therapeutics
6. Biomerieux
7. Danaher Corporation
8. Hal Allergy Group
9. Hitachi Chemical Corporation
10. HOB Biotech Group
11. Hycor Biomedical
12. Lincoln Diagnostics, INC.
13. MEDA Pharmaceuticals
14. NIDEC Corporation
15. Omega Diagnostics Group PLC
16. Quest Diagnostics, INC.
17. Schering-Plough Corporation
18. Siemens AG
19. Stallergenes Greer
20. Thermofisher Corporation
FIGURE #1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
COMPANIES MENTIONED
1. Alcon Laboretries
2. Allercheck INC.
3. Allergen PLC
4. Allergon AB
5. Allergy Therapeutics
6. Biomerieux
7. Danaher Corporation
8. Hal Allergy Group
9. Hitachi Chemical Corporation
10. HOB Biotech Group
11. Hycor Biomedical
12. Lincoln Diagnostics, INC.
13. MEDA Pharmaceuticals
14. NIDEC Corporation
15. Omega Diagnostics Group PLC
16. Quest Diagnostics, INC.
17. Schering-Plough Corporation
18. Siemens AG
19. Stallergenes Greer
20. Thermofisher Corporation
